150 related articles for article (PubMed ID: 10083266)
1. Acceptance of islet allografts transplanted with Fas ligand expressing testicular allografts.
Takeda Y; Gotoh M; Dono K; Grochowiecki TR; Kimura F; Okuyama M; Shimizu J; Nagano H; Umeshita K; Sakon M; Miyasaka M; Monden M
Transplant Proc; 1999; 31(1-2):624. PubMed ID: 10083266
[No Abstract] [Full Text] [Related]
2. Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts.
Takeda Y; Gotoh M; Dono K; Nishihara M; Grochowiecki T; Kimura F; Yoshida T; Ohta Y; Ota H; Ohzato H; Umeshita K; Takeda T; Matsuura N; Sakon M; Kayagaki N; Yagita H; Okumura K; Miyasaka M; Monden M
Diabetologia; 1998 Mar; 41(3):315-21. PubMed ID: 9541172
[TBL] [Abstract][Full Text] [Related]
3. [Synergistic protective effect of testicular cells expressing Fas ligand and cyclosporine A on the survival of islet allografts].
Chen CQ; Zhan WH; Wang JP; Cai SR; He D; Wu XJ; Lan P
Zhonghua Wai Ke Za Zhi; 2003 Nov; 41(11):845-8. PubMed ID: 14703462
[TBL] [Abstract][Full Text] [Related]
4. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.
Lau HT; Yu M; Fontana A; Stoeckert CJ
Science; 1996 Jul; 273(5271):109-12. PubMed ID: 8658177
[TBL] [Abstract][Full Text] [Related]
5. The immunoprotective effect of Sertoli cells coencapsulated with islet xenografts is not dependent upon Fas ligand expression.
Yang H; Al-Jazaeri A; Wright JR
Cell Transplant; 2002; 11(8):799-801. PubMed ID: 12588112
[TBL] [Abstract][Full Text] [Related]
6. Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells.
Dufour JM; Dass B; Halley KR; Korbutt GS; Dixon DE; Rajotte RV
Cell Transplant; 2008; 17(5):525-34. PubMed ID: 18714671
[TBL] [Abstract][Full Text] [Related]
7. Ingested interferon-alpha prevents allograft islet transplant rejection.
Brod SA; Katz S; Phan T; Stepkowski S
Transplantation; 2000 May; 69(10):2162-6. PubMed ID: 10852617
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
[No Abstract] [Full Text] [Related]
9. Islet allografts: rejection and tolerance induction.
Turvey SE; Morris PJ; Wood KJ
Transplant Proc; 1999; 31(1-2):645. PubMed ID: 10083277
[No Abstract] [Full Text] [Related]
10. [Co-transplantation of islet and allogeneic testicular cell induced immune privilege].
Lan P; Yan L; Zhan W; Xiao L
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):208-10. PubMed ID: 11829820
[TBL] [Abstract][Full Text] [Related]
11. A protocol with FK 506 for inducing unresponsiveness to murine islet allografts.
Fukuzaki T; Gotoh M; Monden M; Dono K; Kanai T; Mori T
Surgery; 1995 Feb; 117(2):220-5. PubMed ID: 7531371
[TBL] [Abstract][Full Text] [Related]
12. Cotransplantation with xenogenetic neonatal porcine sertoli cells significantly prolongs islet allograft survival in nonimmunosuppressive rats.
Yin Z; Chen D; Hu F; Ruan Y; Li J; Wang L; Xiang Y; Xie L; Wang X; Ichim TE; Chen S; Chen G
Transplantation; 2009 Aug; 88(3):339-45. PubMed ID: 19667935
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of allograft survival of transfected islets expressing human CTLA4-Ig, human soluble Fas ligand or a combination of the two.
Gainer AL; Suarez-Pinzon WL; Min WP; Hancock-Friesen C; Korbutt GS; Rajotte RV; Rabinovitch A; Warnock GL; Elliott JF
Transplant Proc; 1998 Mar; 30(2):534. PubMed ID: 9532165
[No Abstract] [Full Text] [Related]
14. Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment.
Fukuzaki T; Gotoh M; Monden M; Dono K; Wada H; Kita Y; Kanai T; Mori T
Transplant Proc; 1993 Feb; 25(1 Pt 2):975. PubMed ID: 7680173
[No Abstract] [Full Text] [Related]
15. [Effects of Fas ligand expression on pancreatic islet allografts].
Cai S; Zhan W; He Y
Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):634-7. PubMed ID: 11758207
[TBL] [Abstract][Full Text] [Related]
16. Acceptance of donor-specific islet allografts in rat by intraportal preimmunization with islets and FK 506.
Yasunami Y; Ryu S; Ueki M; Arima T; Ikeda S; Kamei T
Transplant Proc; 1994 Apr; 26(2):722. PubMed ID: 7513467
[No Abstract] [Full Text] [Related]
17. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
[TBL] [Abstract][Full Text] [Related]
18. Testicular Sertoli cells exert both protective and destructive effects on syngeneic islet grafts in non-obese diabetic mice.
Korbutt GS; Suarez-Pinzon WL; Power RF; Rajotte RV; Rabinovitch A
Diabetologia; 2000 Apr; 43(4):474-80. PubMed ID: 10819241
[TBL] [Abstract][Full Text] [Related]
19. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
20. Involvement of Fas and Fas ligand interaction in allogeneic hepatocyte rejection in the spleen.
Kawahara T; Kasai S; Yagita H; Kato K; Sawa M; Nakajima A; Azuma M; Okumura K; Futagawa S; Mito M
Transplant Proc; 1997 Jun; 29(4):2187-8. PubMed ID: 9193582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
